A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma
Background. The use of statins is a potential protective factor against the development of hepatocellular carcinoma. Therefore, we conducted a meta-analysis to evaluate the contribution of statins to the risk of hepatocellular carcinoma. Methods. We searched for PubMed and EMBASE through January 202...
Saved in:
Main Authors: | Yikai Wang, Wenjun Wang, Muqi Wang, Juanjuan Shi, Xiaoli Jia, Shuangsuo Dang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2022/5389044 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of Statin, Metformin, and Aspirin Use With Hepatocellular Carcinoma in the All of Us Research Program
by: Erik Almazan, et al.
Published: (2025-01-01) -
Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis
by: Jie Wang, et al.
Published: (2025-12-01) -
Construction and Analysis of Hepatocellular Carcinoma Prognostic Model Based on Random Forest
by: Yikai Wang, et al.
Published: (2023-01-01) -
Antibiotic Prophylaxis in Transarterial Therapy of Hepatocellular Carcinoma: A Meta-Analysis
by: Jun Wang, et al.
Published: (2012-01-01) -
A Meta-Analysis of Adjuvant Therapy after Potentially Curative Treatment for Hepatocellular Carcinoma
by: Jun Wang, et al.
Published: (2013-01-01)